Oral News and Research

RSS

Multivitamins boost key vitamin levels, but do they improve your health?

A scoping review of 157 clinical trial reports found that multivitamins consistently improved circulating levels of folate, vitamin B6, and vitamin B12, while other nutritional and clinical effects varied by formulation, population, and baseline nutritional status. Selected prenatal and cognitive outcomes improved in some trials, but evidence for cardiovascular disease prevention was largely negative, and the review could not establish the overall certainty of clinical benefits.

29 Oct 2026

Understanding the mechanisms of multilineage coordination during craniofacial development

The human face is one of the most complex structures formed during embryonic development. Its formation requires different cell populations to produce bones, muscles, nerves, blood vessels, teeth, and glands, all arranged in the correct positions and connected to perform their functions.

29 Oct 2026

Simple daily habits to protect and strengthen tooth enamel

In a way, teeth are like little nesting dolls. At the center is the pulp, which contains nerves and blood vessels. Dentin surrounds the pulp, and enamel forms the protective outer covering of the tooth's crown.

29 Oct 2026

Thyroid cancer risks and medication timing with oral GLP-1s

Like most prescriptions, glucagon-like peptide 1 (GLP-1) medications to manage weight come with potential risks.

28 Oct 2026

Nicotine pouches gain rapid popularity among adult tobacco users

A national survey study conducted by the University of Cincinnati found that nicotine pouch use increased sharply in the United States between 2021 and 2024 among adult tobacco users.

28 Oct 2026

Low vitamin B12 is linked to heart disease. Supplements tell a different story

A narrative review published in Nutrition Journal examines how vitamin B12 deficiency may contribute to cardiovascular disease through elevated homocysteine, endothelial dysfunction, oxidative stress and altered methylation. The authors found that B12 supplementation has not consistently prevented heart attacks or cardiovascular deaths in clinical trials, although combined B-vitamin therapy may modestly reduce stroke risk, particularly in populations without folic acid fortification.

27 Oct 2026

Beer and liquor show more oral bacteria links than wine in a large US study

Researchers analyzed beverage intake and oral microbiome data from 5,598 adults across three US cohorts and found that alcohol consumption showed the strongest associations with oral bacterial diversity and composition among the beverages examined. Higher alcohol intake was associated with greater bacterial richness and differences in genera linked to oral health, but the cross-sectional preprint could not establish whether alcohol caused these differences or influenced disease risk.

26 Oct 2026

New drug effectively decreases recurrence of and death from endometrial cancer

A new drug is effective at decreasing recurrence of and death from endometrial cancer, a landmark international study shows.

26 Oct 2026

Next generation KRAS inhibitor divarasib significantly extends lung cancer survival

Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS targeted therapy divarasib, according to researchers from The University of Texas MD Anderson Cancer Center.

26 Oct 2026

Kidney Week 2026 features late-breaking clinical trials in kidney care

The American Society of Nephrology, has selected the following late breaking clinical trials to be presented in-person at Kidney Week 2026 October 22–25.

24 Oct 2026

New guidance expands reproductive care for people with cystic fibrosis

For much of the history of cystic fibrosis (CF) care, reproductive health was not a major part of the conversation. Fertility challenges were the norm for men and women with this genetic disorder, and many grew up assuming biological parenthood was not possible.

23 Oct 2026

Targeted drug extends survival across diverse pancreatic cancer patient groups

A new analysis of a phase 3 clinical trial found that the targeted drug daraxonrasib improved survival compared with standard chemotherapy across multiple groups of patients with advanced pancreatic cancer, including those with different RAS mutations and those without an identified RAS mutation.

23 Oct 2026

BioUK Awards 2026 celebrate outstanding achievement and breakthrough innovations from across the life sciences

BioUK, the not-for-profit membership organization focused on catalyzing success in UK life sciences, today announced the winners of the 18th annual BioUK Awards following a ceremony hosted at the Royal Lancaster Hotel, London.

From BioUK 23 Oct 2026

Fruits and vegetables may be a better option to improve kidney disease outcomes

In people with chronic kidney disease (CKD), oral sodium bicarbonate is a standard treatment for metabolic acidosis (too much acid buildup in the body), but results from a recent clinical trial indicate that dietary acid reduction with base producing fruits and vegetables may be a better option.

22 Oct 2026

$8.2 million grant advances on-demand male contraceptive development

Weill Cornell Medicine has received a four-year, $8.2 million grant from the National Institute of Child Health and Human Development (NICHD) to develop and test an experimental on-demand male contraceptive pill that temporarily stops sperm in their tracks

22 Oct 2026

How microplastics and bacteria interact to drive antibiotic resistance

Microplastics can change how bacteria form biofilms and develop antibiotic resistance. Maria Jazmin Silvero Compagnucci explains.

From Pittcon 22 Oct 2026

Study identifies blood proteins associated with aggressive prostate cancer risk

Proteins linked to the immune system, cell adhesion, blood vessel formation and known prostate cancer genes, were associated with the future risk of developing prostate cancer, including aggressive disease, in a new study led by researchers at Oxford Population Health.

21 Oct 2026

Newer anticoagulants linked to fewer strokes and deaths after brain bleeds

For people with atrial fibrillation (AFib), an irregular heartbeat, and intracranial hemorrhage, a type of stroke also known as a brain bleed, anticoagulant use was associated with a lower risk of an ischemic stroke and death, according to a new study published October 21, 2026, in Neurology®, the official medical journal of the American Academy of Neurology.

21 Oct 2026

Semaglutide and teduglutide reduce immune-driven gut injury in mice

Researchers found that gut-derived GLP-1 and GLP-2 signaling helped protect mice against T cell-induced intestinal injury, with GLP-1R primarily regulating inflammation and GLP-2R supporting intestinal repair. Semaglutide and teduglutide, administered separately or together, reduced acute intestinal damage in mice lacking intestinal proglucagon, suggesting potential avenues for investigating treatments for immune-mediated gut injury.

21 Oct 2026

Glucose priming may improve tumor targeting for chemotherapy nanocarriers

Chemotherapy selectivity is limited by systemic toxicity. pH‑sensitive nanocarriers exploit tumor acidity as a release trigger but respond passively to a modest, heterogeneous gradient.

21 Oct 2026